Clear Point Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Clear Point Advisors’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-418,685	Closed	-$15M	–	104
2026 Q1	$15M	Buy	+418,685	New	+$15.6M	11.61%	1

Other funds holding FFTY

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $171M AUM 36.85% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return

Clear Point Advisors's FFTY Position: Q2 2026 in Review

Clear Point Advisors sold out of CapForce IBD 50 ETF (FFTY) in Q2 2026, closing a stake of 418,685 shares — an estimated $15M sold.

Clear Point Advisors first reported a position in FFTY in Q1 2026 and held it in 1 quarter. The position peaked at $15M in Q1 2026. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

Clear Point Advisors reported no remaining CapForce IBD 50 ETF position as of Q2 2026 after selling out during the quarter.
Clear Point Advisors sold 418,685 CapForce IBD 50 ETF shares in Q2 2026, an estimated $15M.
Clear Point Advisors first reported a position in CapForce IBD 50 ETF in Q1 2026 and held it in 1 quarter.
Clear Point Advisors's CapForce IBD 50 ETF position peaked at $15M in Q1 2026.
33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Clear Point Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.